NGENNasdaqPharmaceutical Preparations

Nervgen Pharma Corp. (NGEN) earnings date, market-implied expected move, and options open interest by expiry

1.34

+0.02 · +1.52%

post 1.34 0.00%

Closed16:00 ET

Open1.27Volume224,387Mkt cap$97.6MEPS-0.44

Day1.27 – 1.4150%52-wk1.28 – 6.301%

NGEN

Nervgen Pharma Corp.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

—

Calendar

Last report

—

Largest filed tie

filed ties

13F top-10 QoQ

+53.97%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

64 managers

Top fund weight

—

No upcoming report date for Nervgen Pharma (NGEN). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

OI · 3 expiries · Oct 28 close

0.02OI · 3 expiries · Oct 28 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

67−60%Nov 2016d3,3460%

3—Jan 1572d0.00806−9%0.00

100%Mar 19135d0.011,895+3%0.01

ExpiryPutsCallsP/C

Nov 2016d67−60%3,3460%0.02

Jan 1572d3—806−9%0.00

Mar 19135d100%1,895+3%0.01

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×0.74· ±3.9% vs ±5.2% · 6 releases

eventrelease day|move|up · n×base

FOMCrate decision±3.9%1 of 6×0.74

CPIconsumer prices±3.7%3 of 9×0.70

PPIproducer prices±3.4%4 of 10×0.66

GDPgross domestic product±2.9%5 of 9×0.55

PCEpersonal income & outlays±2.9%5 of 9×0.55

CPROFcorporate profits±2.0%4 of 6×0.39

NFPjobs report±2.0%3 of 9×0.38

Bar = avg |move| to ±6% · tick = ±5.2% avg day · ×base = |move| ÷ ±5.2% · min 6 releases

Earnings history

No reported quarters.

Methodology

ties · implied moves · holdersMethod